Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2013 - 2026)

Amphastar Pharmaceuticals' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $628.9 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles changed 0.03% year-over-year to $628.9 million; the TTM figure through Mar 2026 stood at $628.9 million (changed 0.03% YoY), while the FY2025 annual figure was $566.0 million, down 9.96% from the prior year.
• Goodwill & Intangibles was $628.9 million for Q1 2026 at Amphastar Pharmaceuticals, up from $566.0 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $635.2 million in Q2 2023 to a low of $37.3 million in Q4 2022.
• Historically, Goodwill & Intangibles has averaged $446.0 million across 5 years, with a median of $613.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles slipped 17.13% in 2022, then jumped 1584.92% in 2023.
• A 5-year view of Goodwill & Intangibles shows it stood at $37.3 million in 2022, then soared by 1544.31% to $613.3 million in 2023, then gained by 2.49% to $628.6 million in 2024, then declined by 9.96% to $566.0 million in 2025, then grew by 11.12% to $628.9 million in 2026.
• The last three Goodwill & Intangibles figures came in at $628.9 million (Q1 2026), $566.0 million (Q4 2025), and $572.2 million (Q3 2025), per Business Quant data.